NRXP NRX Pharmaceuticals, Inc.
Company Analysis
Latest News
NRx Pharmaceuticals Closes Upsized $22.3 Million Public Offering of Common Stock
NRx Pharmaceuticals, Inc. announced the closing of an underwritten public offering of common stock on June 4, 2026, raising approximately $22.3 million in...
🔴 NRX Pharmaceuticals Inc is trading 23.8% down today on a proposed public offering of common stock
NRX Pharmaceuticals Inc is trading 23.8% down at $3.52 after disclosing a proposed underwritten public offering of common stock. • The stock previously fell...
NRX Pharmaceuticals Offers New Shares to Raise Cash, but Can the Stock Recover From a 23% Plunge?
Shares of NRX Pharmaceuticals cratered 23.2% to $3.55 in pre-market trading on June 3, 2026, after the company disclosed plans for an underwritten public...
🔴 NRX Pharmaceuticals Inc is trading 23% down today after announcing a proposed public offering
NRX Pharmaceuticals Inc is trading at $3.55 (23% down) in pre-market sessions after announcing a proposed underwritten public offering of common stock. • The...
NRx Pharmaceuticals Announces Proposed Public Offering of Common Stock
NRx Pharmaceuticals announced on June 2, 2026, its intention to conduct an underwritten public offering of its common stock. The size and terms of the offering...